Skip to main content
SUDARSHAN PHARMA INDUSTRIES LIMITED logo

SUDARSHAN PHARMA INDUSTRIES LIMITED — Investor Relations & Filings

Ticker · 543828 ISIN · INE00TV01023 LEI · 89450093T7PA23ZWJX39 BSE.NS Manufacturing
Open in API
Filings indexed 14 across all filing types
Latest filing 2026-06-05 Regulatory Filings
Country IN India
Listing BSE.NS 543828

About SUDARSHAN PHARMA INDUSTRIES LIMITED

https://www.sudarshanpharma.com

Sudarshan Pharma Industries Limited is a diversified pharmaceutical entity specializing in the manufacturing, sourcing, and distribution of active pharmaceutical ingredients (APIs), specialty chemicals, and pharmaceutical formulations. The company provides a comprehensive range of chemical intermediates and finished dosage forms across various therapeutic categories. Its operational model encompasses contract manufacturing, outsourcing, and the supply of generic medicines to a global clientele. By maintaining an integrated supply chain and technical expertise, the organization facilitates the procurement and production of high-quality chemical components and medicinal products for the healthcare and industrial sectors.

Recent filings

Filing Released Lang Actions
Please find enclosed disclosure under Regulation 31(2) of SEBI (Subtsantial Acquisition of Shares and Takeovers) REgulations, 2011 in connection with intimation of pledge.
Regulatory Filings Classification · 80% confidence The document is an exchange filing disclosing the release of encumbrance (pledge) of promoter shares under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, Regulation 31(1)&(2). It is a regulatory compliance announcement to the stock exchange rather than a financial report, earnings release, management presentation, share issuance, or insider trading notification. There is no specific category for share pledge releases, so it falls under the miscellaneous regulatory announcement category, Regulatory Filings (RNS).
2026-06-05 English
We refer to email dated 18/May/2026, referring to discrepancies in financial results for the QUARTER and financial year ended 31/March/2026. We hereby submit the financial results for ....
Interim / Quarterly Report Classification · 93% confidence The document is a formal stock‐exchange filing under Regulation 33 of SEBI LODR providing the audited standalone financial results (P&L, assets & liabilities, notes) for the half‐year and full year ended March 31, 2026. It contains actual financial statements and detailed disclosures for a period shorter than (and including) a full fiscal year, but it is not a full annual report, proxy, or press release. This aligns with the definition of an Interim / Quarterly Report (IR). FY 2026
2026-06-04 English
Please find enclosed the Annual Secretarial Compliance Report issued by Mr. Vishal Manseta, Company Secretary in Practice, for the financial year ended 31/March/2026.
Regulatory Filings Classification · 90% confidence The document is an "Annual Secretarial Compliance Report" prepared by a Practicing Company Secretary and submitted to the stock exchange in compliance with SEBI Listing Regulations (Reg. 24A). It does not contain financial statements or substantive financial analysis, but rather is an officer’s certification/attestation on regulatory compliance. Under the Certification Rule, such filings should be classified as a general regulatory/stock-exchange filing rather than as an annual or interim report. Therefore, it falls under Regulatory Filings (RNS).
2026-05-30 English
Please find enclosed herewith the newspaper advertisement for the Postal Ballo Notice dispatched to the shareholders of the Company on 25/May/2026 published in (i) Mumbai Lakshdeep and ....
Regulatory Filings Classification · 65% confidence The document is a brief notice from Sudarshan Pharma to the stock exchange stating that a newspaper advertisement for a Postal Ballot Notice has been published and is being enclosed. It contains no financial statements, no board changes, no voting results, no dividend details, nor is it an AGM presentation or full report. It is an announcement to a regulator about publishing shareholder-related paperwork, which does not fit any specific category other than a general regulatory announcement. Therefore it falls under Regulatory Filings (RNS).
2026-05-26 English
Please find enclosed the Notice of Postal Ballot together with Explanatory Statement benig sent to the members of the Company.
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a formal Notice of Postal Ballot sent to shareholders, containing explanatory statements and resolutions, remote e-voting instructions, and requests members to cast votes electronically. It is not an earnings release, audit report, dividend notice, or results announcement, but rather materials soliciting shareholder votes on special resolutions. This corresponds to Proxy Solicitation & Information Statement (PSI).
2026-05-25 English
We refer to the Corporate Announcement dated May 15, 2026, (Annexure A) setting out fixed conversion rate of Rs.95.93 per US Dollar for FCCB issue. RBI rate as on date of signing subscription ....
Capital/Financing Update Classification · 90% confidence The document is an official disclosure to the stock exchange revising the terms of a Foreign Currency Convertible Bond (FCCB) issue (including updated exchange/conversion rate, issuance size, tenure, coupon, etc.). This is clearly an update on the company’s financing activity and capital structure. It is not an AGM material, annual or interim report, earnings release, management changes, voting results, or share repurchase. It falls under ‘Capital/Financing Update’ (CAP).
2026-05-21 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.